Akira Ohara

Prof. Dr. Akira Ohara

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2000
Verified
Journal Article
Closed access
SKS Kojima
S Kojima
SHS Hibi
S Hibi
YKY Kosaka
Y Kosaka
MYM Yamamoto
M Yamamoto
MTM Tsuchida
M Tsuchida
ITI Tsukimoto
I Tsukimoto

1 August 1997
Verified
Journal Article
Closed access
AOAkira Ohara
Akira Ohara
SKS Kojima
S Kojima
NHN Hamajima
N Hamajima
MTM Tsuchida
M Tsuchida
SIS Imashuku
S Imashuku
ITI Tsukimoto
I Tsukimoto

30 July 2018 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
AOAkira Ohara
Akira Ohara
TFTatsuro Furui
Tatsuro Furui
CSChikako Shimizu
Chikako Shimizu
SOSeiichiro Ozono
Seiichiro Ozono
KYKazuhito Yamamoto
Kazuhito Yamamoto
KHKeizo Horibe
Keizo Horibe

15 July 2019 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
AWAtsushi Watanabe
Atsushi Watanabe
TITakeshi Inukai
Takeshi Inukai
KKKeiko Kagami
Keiko Kagami
MAMasako Abe
Masako Abe
MTMasatoshi Takagi
Masatoshi Takagi
KSKanji Sugita
Kanji Sugita
T(17;19)(q21‐q22;p13), responsible for TCF3‐HLF fusion, is a rare translocation in childhood B‐cell precursor acute lymphoblastic leukemia(BCP‐ALL). t(1;19)(q23;p13), producing TCF3‐PBX1 fusion, is a common translocation in childhood BCP‐ALL. Prognosis of t(17;19)‐ALL is extremely poor, while that of t(1;19)‐ALL has recently improved dramatically in intensified chemotherapy. In this study, TCF3‐HLF mRNA was detectable at a high level during induction therapy in a newly diagnosed t(17;19)‐ALL case, while TCF3‐PBX1 mRNA was undetectable at the end of induction therapy in most newly diagnosed t(1;19)‐ALL cases. Using 4 t(17;19)‐ALL and 16 t(1;19)‐ALL cell lines, drug response profiling was analyzed. t(17;19)‐ALL cell lines were found to be significantly more resistant to vincristine (VCR), daunorubicin (DNR), and prednisolone (Pred) than t(1;19)‐ALL cell lines. Sensitivities to three (Pred, VCR, and l ‐asparaginase [ l ‐Asp]), four (Pred, VCR, l ‐Asp, and DNR) and five (Pred, VCR, l ‐Asp, DNR, and cyclophosphamide) agents, widely used in induction therapy, were significantly poorer for t(17;19)‐ALL cell lines than for t(1;19)‐ALL cell lines. Consistent with poor responses to VCR and DNR, gene and protein expression levels of P‐glycoprotein (P‐gp) were higher in t(17;19)‐ALL cell lines than in t(1;19)‐ALL cell lines. Inhibitors for P‐gp sensitized P‐gp‐positive t(17;19)‐ALL cell lines to VCR and DNR. Knockout of P‐gp by CRISPRCas9 overcame resistance to VCR and DNR in the P‐gp‐positive t(17;19)‐ALL cell line. A combination of cyclosporine A with DNR prolonged survival of NSG mice inoculated with P‐gp‐positive t(17;19)‐ALL cell line. These findings indicate involvement of P‐gp in resistance to VCR and DNR in Pgp positive t(17;19)‐ALL cell lines. In all four t(17;19)‐ALL cell lines, RAS pathway mutation was detected. Furthermore, among 16 t(1;19)‐ALL cell lines, multiagent resistance was usually observed in the cell lines with RAS pathway mutation in comparison to those without it, suggesting at least a partial involvement of RAS pathway mutation in multiagent resistance of t(17;19)‐ALL.

1 December 2009 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
DHDaisuke Hasegawa
Daisuke Hasegawa
AMAtsushi Manabe
Atsushi Manabe
HYHiroshi Yagasaki
Hiroshi Yagasaki
YOYoshitoshi Ohtsuka
Yoshitoshi Ohtsuka
MIMasami Inoue
Masami Inoue
OGon behalf of Japanese Childhood MDS Study Group
on behalf of Japanese Childhood MDS Study Group

8 April 2021 in Journal of Medical Microbiology
Verified
Journal Article
Open access
HMHiroe Konishi McKee
Hiroe Konishi McKee
CKChiaki Kajiwara
Chiaki Kajiwara
TYTetsuo Yamaguchi
Tetsuo Yamaguchi
YIYoshikazu Ishii
Yoshikazu Ishii
NSNorikazu Shimizu
Norikazu Shimizu
KTKazuhiro Tateda
Kazuhiro Tateda
Introduction.Clostridioides difficileinfection (CDI) causes toxin-mediated enteropathy, such as antibiotic-associated diarrhoea and pseudomembranous colitis. Rho-glucosylating toxin A (TcdA) and toxin B (TcdB) have been clearly implicated in pathogenesis, whereas the virulence of binary toxin (CDT) is still debated.Hypothesis statement.We hypothesized that CDT is involved in the host immune response and plays a pivotal role in establishing virulence by modulating pro-inflammatory cytokine production; this is achieved through the integral Toll-like receptor (TLR) signalling pathways.Aim.The aim of the present study was to determine whether and how CDT impacts macrophages compared to TcdA or TcdB by examining the induction of CXC chemokine ligand 2 (CXCL2) and tumour necrosis factor-α (TNF-α), both of which are crucial in mediating local and systematic inflammatory responses.Methodology.RAW264.7 cells or transfected human embryonic kidney (HEK) 293 T cells were incubated with TcdA, TcdB, or CDT. In some experiments, a neutralizing antibody against TLR2 or TLR4, or myeloid differentiation 88 inhibitory peptide were added. The amount of CXCL2 and TNF-α secreted was then measured.Results.In RAW264.7 macrophages, CXCL2 and TNF-α were produced via the Toll-like receptor 2 (TLR2) or Toll-like receptor 4 (TLR4) pathway in a TcdA, TcdB, or CDT dose-dependent manner. Interleukin-8 secretion was induced in TLR4/MD2/CD14-transfected, but not in TLR2-transfected, HEK 293 T cells following TcdB or CDT exposure.Conclusion.Our results showed thatC. difficiletoxins, including CDT, enhanced macrophage-mediated CXCL2 and TNF-α production via TLR2 and TLR4, indicating that CDT affects host immune responses.